March 18 (Reuters) - Pfizer (PFE.N), opens new tab will sell its remaining stake in British consumer healthcare group Haleon (HLN.L), opens new tab, the companies said on Tuesday. Pfizer will sell ...

Haleon to invest $54 mln in US R&D centre to ... invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new product innovations.

(Bloomberg) -- Pfizer Inc. raised about £2.55 billion ($3.3 billion) through the sale of its remaining 7.3% stake in Haleon Plc, culminating a years-long separation from the maker of Sensodyne ...

Pfizer Inc. is poised to raise about £2.55 billion ($3.3 billion) through the sale of its remaining 7.3% stake in Haleon Plc, culminating a years-long separation from the maker of Sensodyne ...

Haleon HLN-2.04%decrease; red down pointing triangle posted a higher pretax profit for 2024 despite lower revenue, and said it expected further organic revenue and profit growth this year. The ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

British consumer healthcare group Haleon disappointed investors on Thursday after the Sensodyne toothpaste maker said 2025 revenue growth would be weighted to the second half of the year ...

LONDON - Haleon plc (LSE/NYSE: HLN), a global leader in consumer health, has announced an agreement with Pfizer Inc. (NYSE:PFE) to buy back approximately £170 million worth of its ordinary shares.

In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against the other pharma stocks. Healthcare, which includes numerous businesses that offer patient care ...